Teladoc Health, Inc. · NYSE:TDOC
Teladoc Health — Q2 2026 Earnings Presentation
14 slides from Teladoc Health's earnings presentation, Jul 29, 2026
Slide 1: 2Q-26 Quarterly Results
HEALTH Teladoc SS OG 2Q-26 Quarterly Results
Slide 2: Cautionary Note
Cautionary Note • This presentation contains, and the officers of Teladoc Health, Inc. (the “Company” or “Teladoc Health”) may make, “forward-looking” statements that are based on management’s beliefs and assumptions and on information currently available to management. These forward-looking stateme
Slide 3: Key Financial Data
Key Financial Data 2Q-26 Adj. 2Q-26 Revenue of 2Q-26 Net loss per EBITDA(2) of $607M, (4)% y/y share of $(0.21)(1) $65.7M, (5)% y/y FY-26 Revenue outlook range FY-26 Net loss per share FY-26 Adj. EBITDA outlook of $2,362M to $2,447M outlook range of range of $271M to $303M $(1.00) to $(0.75) • 3Q-26
Slide 4: 2Q-26 Consolidated Revenue & Adj. EBITDA
2Q-26 Consolidated Revenue & Adj. EBITDA Revenue ($ millions) Adj. EBITDA ($ millions)(1) (1) See reconciliation of GAAP to non-GAAP measures included in the Appendix of this presentation. © Teladoc Health, Inc. All rights reserved. 4
Slide 5: Quarterly Segment Results
Quarterly Segment(1) Results Integrated Care Segment Revenue ($ millions) BetterHelp Segment Revenue ($ millions) Integrated Care Segment Adjusted EBITDA ($ millions) BetterHelp Segment Adjusted EBITDA ($ millions) (1) The Company has two reportable segments: Integrated Care and BetterHelp. The Inte
Slide 6: 2Q-26 Revenue: U.S. & International
2Q-26 Revenue: U.S. & International U.S. Revenue ($ millions) International Revenue ($ millions) © Teladoc Health, Inc. All rights reserved. 6
Slide 7: Quarterly Key Operating Metrics
Quarterly Key Operating Metrics U.S. Integrated Care Members(1) (millions) BetterHelp Paying Users(2) (thousands) Average Monthly Revenue per Chronic Care Program Enrollment(4) (thousands) U.S. Integrated Care Member(3) 1. U.S. Integrated Care Members represent the number of unique individuals at th
Slide 8: Quarterly Adjusted EBITDA & Adjusted EBITDA Margin
Quarterly Adjusted EBITDA & Adjusted EBITDA Margin Adj. EBITDA(1) ($ millions) & Adj. EBITDA Margin (1) See reconciliation of GAAP to non-GAAP measures included in the Appendix of this presentation. © Teladoc Health, Inc. All rights reserved. 8
Slide 9: Balance Sheet and Cash Flow Highlights
Balance Sheet and Cash Flow Highlights • Cash and Cash Equivalents (as of June 30, 2026): $774M • Convertible Senior Notes (as of June 30, 2026): $997M • Operating Cash Flow (2Q-26): $65M • Free Cash Flow (1) (2Q-26): $36M (1) See reconciliation of GAAP to non-GAAP measures included in the Appendix
Slide 10: Outlook: 3Q-26 and FY-26
Outlook: 3Q-26 and FY-26 3Q-26 Y/Y % Growth FY-26 Y/Y % Growth Revenue ($M) $569 to $609 (9)% to (3)% $2,362 to $2,447 (7)% to (3)% Net loss per share $(0.30) to $(0.20) NM $(1.00) to $(0.75) NM Adj. EBITDA ($M) $62 to $74 (11)% to 6% $271 to $303 (4)% to 8% US Integrated Care 99.0 to 100.5 (3)% to
Slide 11: Appendix
Appendix Teladoc HEALTH
Slide 12: Reconciliation of GAAP Net Loss to Adjusted EBITDA
Reconciliation of GAAP Net Loss to Adjusted EBITDA 2Q-25 3Q-25 4Q-25 1Q-26 2Q-26 Net loss $(32,660) $(49,507) $(25,143) $(63,837) $(38,908) Add: Provision for income taxes (7,763) (715) (8,475) 2,995 997 Other expense (income), net (8,371) 815 (378) 196 2,191 Interest expense 4,473 4,526 4,950 5,368
Slide 13: Reconciliation of GAAP Net Cash Provided by Operating Activities to Free Cash Flow
Reconciliation of GAAP Net Cash Provided by Operating Activities to Free Cash Flow 2Q-26 Net cash provided by operating activities $64,662 Capital expenditures (928) Capitalized software development costs (27,990) Capex (28,918) Free Cash Flow $35,744 (in 000s) © Teladoc Health, Inc. All rights rese
Slide 14: Teladoc Health
Teladoc HEALTH